Editas Medicine(CH:8EM)
CHF 2.05+0.01 (+0.29%)
CH:8EM
Editas Medicine hedge funds
CHF 2.05
At close:+0.01 (+0.29%)
Editas Medicine (8EM) Hedge Fund Trading Activity
1 Followers
Trend: ▲ Hedge Funds Increased Holdings by 12.5M Shares Last Quarter
Hedge Fund Holdings in 8EM
Currently, no data available
Please return soon. This page is being updated.
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 Kenneth Tropin | Graham Capital Management, L.P. | Added | 108.55% | $286,803 | <0.01% | ||
 Andrew Alkon | EntryPoint Capital, LLC | New | 100.00% | $173,335 | 0.07% | ||
| Antony J. Abbiati | SCS Capital Management LLC | Not Changed | 0.00% | $71,750 | <0.01% |
FAQ
Which hedge funds hold Editas Medicine?
The hedge funds that hold the most shares in Editas Medicine are Kenneth Tropin, Andrew Alkon and Antony J. Abbiati.
Are hedge funds buying or selling CH:8EM?
In the last quarter hedge funds have Increased their holdings in Editas Medicine by 12.5M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Editas Medicine stock?
Warren Buffet currently does not own shares in Editas Medicine.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
